MIRATI Trademark

Trademark Overview

On Friday, June 25, 2021, a trademark application was filed for MIRATI with the United States Patent and Trademark Office. The USPTO has given the MIRATI trademark a serial number of 90796207. The federal status of this trademark filing is REGISTERED as of Tuesday, September 12, 2023. This trademark is owned by Mirati Therapeutics, Inc.. The MIRATI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention and/or treatment of cancer; pharmaceutical preparations for use in oncology
mirati

General Information

Serial Number90796207
Word MarkMIRATI
Filing DateFriday, June 25, 2021
Status700 - REGISTERED
Status DateTuesday, September 12, 2023
Registration Number7164949
Registration DateTuesday, September 12, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2021

Trademark Statements

Goods and Servicespharmaceutical preparations for the prevention and/or treatment of cancer; pharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 9, 2021
Primary Code005
First Use Anywhere DateTuesday, December 13, 2022
First Use In Commerce DateTuesday, December 13, 2022

Trademark Owner History

Party NameMirati Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameMirati Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameMirati Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, June 29, 2021NEW APPLICATION ENTERED
Thursday, September 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 1, 2021ASSIGNED TO EXAMINER
Monday, November 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 14, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 8, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 8, 2022SOU EXTENSION 1 FILED
Monday, August 8, 2022SOU EXTENSION 1 GRANTED
Wednesday, August 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 2, 2023TEAS STATEMENT OF USE RECEIVED
Monday, January 2, 2023USE AMENDMENT FILED
Monday, January 30, 2023SOU TEAS EXTENSION RECEIVED
Monday, January 30, 2023SOU EXTENSION 2 FILED
Monday, January 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, February 4, 2023SOU EXTENSION 2 GRANTED
Tuesday, February 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 8, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 8, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 9, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 12, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

mirati pharmaceutical preparations oncology cancer prevention treatment